Pharmacology

10-Year Data Evaluating Adalimumab For Patients With Moderate-to-Severe Rheumatoid Arthritis

BERLIN, June 6, 2012-- Abbott today announced results from two long-term, open-label studies, which evaluated the results of HUMIRA® (adalimumab) treatment for up to 10 years in patients with long-standing, moderate-to-severe rheumatoid arthritis (RA). Th ...

Article - Newswire - Jun 6 2012 - 10:06am

5-Year Data For Ustekinumab Show Consistent Efficacy And Safety For Moderate To Severe Plaque Psoriasis

HIGH WYCOMBE, England, June 6, 2012  -- Findings from a psoriasis clinical development program for a biologic following patients continuously for five years provide insights on the long-term response and safety profile of ustekinumab. New efficacy and saf ...

Article - Newswire - Jun 6 2012 - 11:30am

In Study, Male Sexual Dysfunction Improved With Saw Palmetto Extract

A natural treatment made from Saw Palmetto berries can have a significant effect in reducing sexual dysfunction in men with prostate problems, a new clinical trial found. A male libido study carried out by Swiss-based herbal specialists A. Vogel used extr ...

Article - Newswire - Jun 14 2012 - 4:00am

Positive Phase 2 Study Results For Tivantinib In Hepatocellular Carcinoma

ArQule, Inc. and Daiichi Sankyo Co., Ltd. announced final results from a randomized, placebo-controlled, double-blind, phase 2 clinical trial with the selective MET inhibitor tivantinib as a single-agent, investigational, second-line treatment in hepatoce ...

Article - Newswire - Jun 12 2012 - 2:00pm

An International Call To Action To Alleviate Drug Shortages

Society is in a tough spot. Drug companies are culturally vilified and routinely sued when things go bad- all in return for only a few years of profitability before anyone can make the new drugs they develop- the FDA is constantly under pressure to expedi ...

Article - News Staff - Jun 18 2012 - 1:00pm

The Secret History Of Pain Killers

Looking at the latest statistics, it’s hard to miss one compelling trend: The over-prescription of painkillers is slowly but surely eclipsing the problem of illegal drugs. There are, of course, the usual culprits in this disturbing trend- from HMOs and the ...

Article - Greg Critser - Jun 20 2012 - 12:42pm

Miracle Cure Of The Week: Daffodils May Fix Depression

Plant compounds from a South African daffodil may be used to treat depression, according to a University of Copenhagen study, where they tested those substance in a laboratory model of the blood-brain barrier. Substances from the South African plant specie ...

Article - News Staff - Jun 22 2012 - 3:30pm

Want To Stay Thin? There's A Vaccine For That

A new study has assessed the effectiveness of two somatostatin vaccinations, JH17 and JH18, in reducing weight gain and increasing weight loss in mice. Somatostatin is a peptide hormone which inhibits the action of growth hormone (GH) and insulin-like grow ...

Article - News Staff - Jul 8 2012 - 6:30pm

Ayurvedic Remedy Gets Studied: Frankincense For Asthma?

Science 2.0 fave Dr. Neil deGrasse Tyson recently sent a funny thing across his Twitter feed: Q: What do you call Alternative Medicine that survives double-blind laboratory tests? A: Regular Medicine. And that's the crux of the issue, isn't it?   ...

Article - Hank Campbell - Jul 10 2012 - 5:00am

Janssen Submits Applications Requesting Approval Of SIMPONI® In U.S. And Europe For Treatment Of Ulcerative Colitis

Janssen Biotech, Inc. and Janssen Biologics B.V. announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMA) requesting appro ...

Article - Newswire - Jul 16 2012 - 9:28pm